1. Home
  2. Analysis
  3. Alvesco
  4. Pancreatitis-relapsing

Alvesco and Pancreatitis relapsing - a phase IV clinical study of FDA data

Summary:

Pancreatitis relapsing is reported as a side effect among people who take Alvesco (ciclesonide), especially for people who are female, 10-19 old, also take Gravol,.

The phase IV clinical study analyzes which people have Pancreatitis relapsing when taking Alvesco. It is created by eHealthMe based on reports of 13,009 people who have side effects when taking Alvesco from the FDA, and is updated regularly.

What is Alvesco?

Alvesco has active ingredients of ciclesonide. It is often used in asthma. eHealthMe is studying from 13,134 Alvesco users. Check the latest studies of Alvesco.

What is Pancreatitis relapsing?

Pancreatitis relapsing is found to be associated with 176 drugs and 298 conditions by eHealthMe. Check the latest studies of Pancreatitis relapsing.

On Jul, 12, 2026

13,009 people reported to have side effects when taking Alvesco.
Among them, 36 people (0.28%) have Pancreatitis relapsing.

Could Alvesco cause Pancreatitis relapsing?

Among these 36 people:

What is the gender of people who have Pancreatitis relapsing when taking Alvesco? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Pancreatitis relapsing when taking Alvesco? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 100 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other drugs people take besides Alvesco? *

  1. Gravol: 36 people, 100.00%
  2. Ventolin: 35 people, 97.22%
  3. Spiriva: 34 people, 94.44%
  4. Ursodiol: 26 people, 72.22%
  5. Mometasone Furoate: 26 people, 72.22%
  6. Montelukast Sodium: 20 people, 55.56%
  7. Formoterol Fumarate: 19 people, 52.78%
  8. Amitriptyline Hydrochloride: 17 people, 47.22%
  9. Citalopram Hydrobromide: 12 people, 33.33%
  10. Sodium Bicarbonate: 2 people, 5.56%

What are other side effects people have besides Pancreatitis relapsing? *

  1. Urinary Retention (the inability to completely or partially empty the bladder): 36 people, 100.00%
  2. Stress And Anxiety: 36 people, 100.00%
  3. Allergic Sinusitis: 36 people, 100.00%
  4. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 36 people, 100.00%
  5. Chest Pain: 36 people, 100.00%
  6. Cough: 36 people, 100.00%
  7. Depression: 36 people, 100.00%
  8. Dyspnea (difficult or laboured breathing): 36 people, 100.00%
  9. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 36 people, 100.00%
  10. Hypersensitivity: 36 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Alvesco and have Pancreatitis relapsing?

- Check whether Pancreatitis relapsing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alvesco:

Pancreatitis relapsing treatments and more:

How severe was Pancreatitis relapsing and when was it recovered:

Expand to all the drugs that have ingredients of ciclesonide:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alvesco:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pancreatitis relapsing:

Browse all the conditions that are associated with Pancreatitis relapsing:

How the study uses the data?

The study uses data from the FDA. It is based on ciclesonide (the active ingredients of Alvesco) and Alvesco (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.